About The Report
The global licorice extract market was valued at USD 949.80 Million in 2026 and is projected to reach USD 1,733.31 Million by 2036, expanding at a CAGR of 6.20% during the forecast period.
Market expansion is being structurally shaped by the transition from bulk licorice root procurement toward concentration-defined extract sourcing, where glycyrrhizin band specification, derivative purity, and documented assay reproducibility determine commercial qualification. Unlike commodity botanical sourcing, extract transactions are increasingly governed by concentration thresholds and compliance-grade documentation, which shifts purchasing power toward processors that can standardize active compound profiles at scale. Medium Glycyrrhizin concentration between 10 to 30% accounts for 28.6% of total active compound share, positioning this band as the operating benchmark for balancing potency, yield efficiency, and formulation compatibility across regulated and semi-regulated end uses.

Product type distribution reflects differentiated end-use integration and processing depth. Powdered Solid Extract, representing 16.9% of product share, functions as the structural backbone of the market due to compatibility with capsule filling, tablet compression, dry blending, and standardized premix systems. Blocks and paste variants remain material in confectionery and tobacco flavoring workflows where sweetness modulation and flavor extension are prioritized. Liquid formats, including aqueous and hydroalcoholic extracts, are selected when solubility and dispersion control matter more than transport efficiency, particularly in respiratory and gastrointestinal applications. Standardized Glycyrrhizin Extract accounts for 8.1% of product share, indicating rising procurement of concentration-certified materials. Highly Purified Derivatives represent 6.1% of product share, reinforcing a parallel shift toward higher processing intensity where buyers pay for documented purity, defined performance, and reduced variability.
Application segmentation underscores multi-industry stability and contract flexibility. Nutraceutical and Dietary Supplements lead with 13.9% share, followed by Confectionery at 13.4% and Cosmetics and Personal Care at 10.8%. Respiratory Formulations account for 10.6%, highlighting structured pharmaceutical integration, while Tobacco Flavoring maintains 8.5% share due to established sweetening and flavor enhancement use. This diversified demand matrix reduces concentration risk and enables processors to allocate production across grades, forms, and concentration bands based on contract structures, documentation requirements, and margin optimization.
On the supply side, extraction method selection directly influences solids recovery, cost per active unit, and export suitability. Water and hydroalcoholic extraction remain foundational for base throughput due to cost efficiency and scalability, while solvent and supercritical systems support higher concentration targets and enriched fractions at higher capital intensity. Over the forecast period, sustained growth will be underpinned by concentration standardization, derivative portfolio expansion, yield-optimized processing economics, and compliance documentation depth rather than agricultural acreage expansion alone.
Demand for licorice extract is expanding as end-use industries increasingly prioritize concentration-defined botanical inputs over raw licorice root. Pharmaceutical and nutraceutical manufacturers require reproducible glycyrrhizin profiles to ensure formulation consistency, regulatory compliance, and dosage precision. Medium Glycyrrhizin concentration between 10 to 30% accounts for 28.6% of active compound share, underscoring market preference for balanced potency that supports therapeutic and supplement applications without requiring excessive purification intensity.
Respiratory Formulations represent 10.6% of total application share, demonstrating structured pharmaceutical demand. Gastrointestinal Treatments and Traditional Medicine Systems also contribute materially, supported by Deglycyrrhizinated extract variants that account for 8.4% of the active compound profile. These derivatives mitigate glycyrrhizin-associated side effects while preserving flavonoid functionality, expanding clinical and nutraceutical applicability.
Nutraceutical and Dietary Supplements lead application segmentation at 13.9% share, reflecting integration into capsules, powders, herbal blends, and functional formulations. Confectionery holds 13.4% share, maintaining volume demand as a natural sweetener and flavor enhancer. Cosmetics and Personal Care represent 10.8%, leveraging flavonoid or glabridin-enriched extracts for skin brightening and anti-inflammatory positioning. This diversified application mix distributes demand across therapeutic, functional, and flavor-driven categories, reducing exposure to single-industry cyclicality.
From a product format perspective, Powdered Solid Extract holds 16.9% share due to compatibility with dry blending, encapsulation, and bulk export logistics. Aqueous and Hydroalcoholic Extracts serve liquid systems requiring solubility precision and controlled dispersion. Extraction method selection influences solids recovery rates, solvent efficiency, and cost per active compound unit. Manufacturers integrating spray drying and vacuum concentration achieve improved moisture regulation and batch stability, strengthening export-grade consistency.
Demand growth is therefore anchored in formulation performance reliability, concentration standardization, derivative expansion, and yield-optimized processing economics rather than agricultural acreage expansion alone.
The global licorice extract market is segmented by Product Type, Application, and Active Compound Profile, reflecting processing depth, end-use allocation, and concentration-based differentiation. Product Type includes blocks, paste, powder, granules, aqueous extract, hydroalcoholic extract, oil-soluble extract, concentrated liquid extract, standardized glycyrrhizin extract, and highly purified derivatives. Application spans confectionery, bakery, dairy, beverages, savory and seasonings, tobacco flavoring, respiratory formulations, gastrointestinal treatments, nutraceutical and dietary supplements, traditional medicine systems, cosmetics and personal care, and animal feed and veterinary. Active Compound Profile distinguishes low glycyrrhizin, medium glycyrrhizin, high glycyrrhizin, ultra-high glycyrrhizin, deglycyrrhizinated extract, and flavonoid or glabridin-enriched extract. These segmentation layers collectively capture commercial positioning across concentration thresholds, processing intensity, and application compatibility.

22.7% of the market is accounted for by Medium Glycyrrhizin concentration extracts. This segment leads because it balances functional potency with cost-efficient extraction yield. Medium concentration variants deliver sweetness and anti-inflammatory properties suitable for pharmaceutical, nutraceutical, and confectionery formulations without requiring the capital-intensive purification necessary for ultra-high concentration derivatives.
From a procurement standpoint, this concentration band allows cross-application flexibility across respiratory, gastrointestinal, supplement, and food systems while maintaining standardized labeling compliance. Compared with High Glycyrrhizin extracts at 18.9% and Ultra-High at 10.8%, medium concentration products provide optimal cost-to-performance alignment for large-volume contracts.
Extraction processes targeting medium concentration require lower solvent intensity and fewer purification cycles, supporting throughput efficiency and margin stability. This combination of economic viability, regulatory compatibility, and multi-sector applicability sustains structural dominance within active compound segmentation.

13.8% of the market is accounted for by Powdered Solid Extract. Powder format leadership is driven by compatibility with encapsulation, tablet compression, dry blending, and standardized premix operations. Powdered extract enables precise dosage measurement, controlled particle distribution, and stable storage under regulated humidity conditions.
Spray drying and vacuum concentration technologies allow moisture regulation and improved solids consistency, strengthening batch reproducibility and export stability. Compared with liquid extracts, powder reduces transport weight and packaging complexity, enhancing logistics efficiency.
From a supply chain perspective, powdered format supports ambient storage and broad geographic distribution without cold-chain dependency. Its ability to integrate seamlessly into pharmaceutical, nutraceutical, confectionery, and cosmetic workflows reinforces its leading share position within the global licorice extract market.
Processing efficiency remains a core structural lever in the global licorice extract market, particularly as buyers increasingly procure concentration-defined materials rather than raw botanical inputs. Extraction method selection directly influences glycyrrhizin recovery rates, solvent utilization intensity, solids yield, and cost per active compound unit. Water and hydroalcoholic extraction systems continue to anchor baseline throughput due to scalability and cost efficiency, while solvent-based and supercritical systems are selectively deployed for higher concentration bands and enriched fractions. Yield optimization strategies, including improved filtration, concentration cycling, and solids stabilization, determine whether processors can maintain margin integrity across medium and high glycyrrhizin profiles. Integration of spray drying and vacuum concentration enhances moisture control and batch reproducibility, reinforcing documentation consistency required by pharmaceutical-grade and food-grade buyers.
Commercial differentiation in the licorice extract market is increasingly structured around clearly defined glycyrrhizin concentration bands and derivative purity levels. Medium Glycyrrhizin concentration between 10 to 30% holds 28.6% share, reflecting demand for balanced potency and processing efficiency. Standardized glycyrrhizin extracts and highly purified derivatives enable tiered pricing architectures aligned with regulatory-grade documentation requirements. Buyers are prioritizing concentration-certified inputs that support consistent labeling, dosage precision, and reproducible formulation performance. This standardization trend shifts competitive advantage toward processors capable of delivering validated assay documentation across batch cycles, rather than those operating primarily on raw material sourcing scale. Concentration clarity has therefore become a strategic differentiator influencing long-term supply agreements and qualification status within regulated industries.
Derivative expansion represents a structural pathway for margin enhancement within the licorice extract market. Highly Purified Derivatives account for 6.1% of product share, while Deglycyrrhizinated extracts represent 8.4% within the active compound profile. These formats extend applicability across gastrointestinal, cosmetic, and specialized nutraceutical formulations by mitigating glycyrrhizin-associated side effects while preserving flavonoid functionality. Development of glycyrrhizinate salts and flavonoid-enriched fractions allows processors to serve targeted functional requirements beyond baseline sweetness and anti-inflammatory properties. However, derivative production requires additional purification cycles, solvent management, and documentation rigor, increasing capital intensity. Companies that integrate derivative production within scalable extraction infrastructure strengthen value capture potential while diversifying revenue streams across regulated end-use segments.
Global licorice extract market expansion over 2026 to 2036 is shaped by pharmaceutical formulation intensity, nutraceutical penetration, and structured ingredient procurement frameworks. Countries with advanced manufacturing infrastructure and compliance-driven sourcing practices demonstrate stronger value contribution. Concentration-defined extracts and derivative adoption determine growth trajectories more than agricultural output alone. Regulatory documentation standards, assay reproducibility requirements, and integration into multi-industry supply chains influence regional performance. Differences in application mix, import dependency, and extraction capacity create varied CAGR outcomes across leading markets while maintaining structural alignment with concentration standardization trends.

| Country | Country CAGR |
|---|---|
| USA | 5.80% |
| China | 7.10% |
| India | 7.40% |
| Germany | 5.30% |
| Japan | 4.70% |
| UK | 5.10% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research
The United States holds the largest share in the global licorice extract market, supported by advanced pharmaceutical and nutraceutical manufacturing infrastructure and structured procurement contracts emphasizing concentration-certified botanical inputs. Demand is reinforced by integration into respiratory formulations, gastrointestinal treatments, and dietary supplements requiring documented glycyrrhizin profiles and reproducible assay results. Pharmaceutical-grade classification systems and labeling requirements elevate the importance of supplier traceability and purification depth. Import dependency for botanical extracts further strengthens procurement standardization and compliance-driven sourcing. The combination of regulated application intensity, established formulation systems, and concentration-based purchasing frameworks sustains the country’s leadership position within the global market structure.
China records a CAGR of 7.10%, reflecting strong integration between cultivation sourcing and extract processing infrastructure. The country supports both domestic application demand and export-oriented production of standardized glycyrrhizin extracts and derivatives. Traditional medicine systems and food processing applications contribute materially to demand allocation. Integration of extraction capacity with local root supply enables yield optimization and cost control across concentration bands. Investment in purification and drying systems supports higher-value derivative production and export eligibility. The country’s balanced domestic consumption and export positioning reinforce structural growth momentum during the forecast period.
India registers the highest CAGR at 7.40% during 2026 to 2036. Growth is supported by expanding nutraceutical and pharmaceutical manufacturing capacity requiring standardized botanical extracts. Concentration-defined procurement frameworks are increasingly adopted within supplement and therapeutic product development. Integration of solvent extraction and spray drying systems enhances domestic processing capability and export participation. Regulatory documentation requirements for botanical ingredients reinforce demand for assay-certified extracts. The country’s alignment with concentration standardization and derivative portfolio expansion contributes to accelerated growth relative to other markets within the forecast horizon.
Germany records a CAGR of 5.30%, supported by pharmaceutical-grade procurement and strict quality documentation standards. The country’s emphasis on validated assay reporting, traceability documentation, and compliance alignment strengthens demand for standardized glycyrrhizin extracts and purified derivatives. Integration into respiratory and gastrointestinal formulations reinforces therapeutic demand stability. Import-based sourcing combined with stringent regulatory oversight elevates supplier qualification thresholds, reinforcing concentration-based differentiation. Stable demand growth reflects regulatory rigor and mature formulation infrastructure rather than rapid volume expansion.
Japan registers a CAGR of 4.70%, reflecting stable integration of licorice extract into traditional medicine systems and regulated nutraceutical formulations. Concentration-certified extracts are required to meet documentation standards within therapeutic applications. Application diversification across supplements, functional beverages, and cosmetic formulations sustains baseline demand. Emphasis on formulation precision and active compound reproducibility supports continued procurement of standardized and derivative formats. Growth remains moderate due to market maturity but structurally aligned with concentration-defined sourcing frameworks.
The UK records a CAGR of 5.10%, supported by nutraceutical and food application demand requiring documented concentration levels and traceability compliance. Import reliance for botanical extracts reinforces structured procurement systems emphasizing assay validation and derivative clarity. Application integration within dietary supplements and confectionery maintains stable consumption patterns. Regulatory oversight and labeling standards support preference for standardized extracts over non-specified materials. Moderate growth reflects structured demand within regulated segments rather than rapid expansion across new application categories.

The competitive landscape of the global licorice extract market is moderately fragmented, with the top fourteen named companies collectively accounting for 75.70% of total market share and Others representing 24.30%. Mafco Worldwide LLC leads with 12.40% share, followed by Norevo GmbH at 10.20% and Maruzen Pharmaceuticals Co., Ltd. at 8.80%. Mid-tier participants including F&C Licorice Ltd., Zagros Licorice Co., and Sepidan Osareh Co. maintain meaningful positions through integration of extraction and purification operations.
Competitive differentiation is increasingly structured around purification depth, derivative portfolio breadth, and concentration standardization capability. Companies investing in solvent optimization, hydroalcoholic extraction scaling, and advanced drying systems strengthen yield control and batch reproducibility. Standardized glycyrrhizin extract production at 8.1% product share and Highly Purified Derivatives at 6.1% reflect growing emphasis on higher processing intensity formats.
Strategic positioning also involves alignment with regulated industries requiring validated documentation and traceability. Companies capable of delivering medium glycyrrhizin concentration profiles, which account for 28.6% of active compound share, reinforce commercial leadership by serving the largest demand band.
Recent Developments:
The global licorice extract market refers to the structured commercial ecosystem involved in the extraction, concentration, purification, standardization, and bulk distribution of licorice-derived active compounds sourced primarily from Glycyrrhiza species, including Glycyrrhiza glabra, Glycyrrhiza uralensis, and Glycyrrhiza inflata. The market scope encompasses manufacturer-level sales of processed licorice extracts in defined concentration bands and derivative forms intended for industrial, pharmaceutical, nutraceutical, cosmetic, food, and tobacco applications.
Licorice extract within this market context includes solid formats such as blocks, paste, powder, and granules; liquid formats including aqueous, hydroalcoholic, oil-soluble, and concentrated liquid extracts; standardized glycyrrhizin extracts; and highly purified derivatives such as deglycyrrhizinated extract and glycyrrhizinate salts. Market valuation captures bulk ingredient transactions at the processor or manufacturer level and excludes finished consumer goods that contain licorice as an ingredient.
Active compound differentiation forms a central analytical pillar of this market. Concentration bands include low glycyrrhizin below 10%, medium glycyrrhizin between 10 to 30%, high glycyrrhizin between 30 to 60%, ultra-high glycyrrhizin above 60%, deglycyrrhizinated extract, and flavonoid or glabridin-enriched variants. These concentration categories determine pricing tiers, regulatory classification alignment, and formulation compatibility across industries.
Processing methods within scope include water extraction, ethanol extraction, hydroalcoholic extraction, solvent extraction, supercritical extraction, spray drying, and vacuum concentration. These methods influence solids recovery rates, solvent efficiency, purification depth, moisture stability, and export readiness.
The market excludes raw licorice root trading without extraction, synthetic sweetener substitutes unrelated to licorice, finished confectionery or supplement retail sales, and non-botanical flavoring systems. Only bulk extract and derivative ingredient-level transactions are considered within the defined market boundary.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 949.80 Million |
| Forecast Value (2036) | USD 1,733.31 Million |
| CAGR (2026 to 2036) | 6.20% |
| Product Type | Blocks (Solid Extract), Paste (Solid Extract), Powder (Solid Extract), Granules (Solid Extract), Aqueous Extract (Liquid), Hydroalcoholic Extract (Liquid), Oil-Soluble Extract (Liquid), Concentrated Liquid Extract, Standardized Glycyrrhizin Extract, Highly Purified Derivatives |
| Active Compound Profile | Low Glycyrrhizin (Below 10%), Medium Glycyrrhizin (10 to 30%), High Glycyrrhizin (30 to 60%), Ultra-High Glycyrrhizin (Above 60%), Deglycyrrhizinated Extract, Flavonoid or Glabridin-Enriched Extract |
| Application | Confectionery, Bakery, Dairy, Beverages (Functional, RTD, Herbal), Savory and Seasonings, Tobacco Flavoring, Respiratory Formulations, Gastrointestinal Treatments, Nutraceutical and Dietary Supplements, Traditional Medicine Systems, Cosmetics and Personal Care, Animal Feed and Veterinary |
| Extraction Method | Water Extraction, Ethanol Extraction, Hydroalcoholic Extraction, Solvent Extraction, Supercritical Extraction, Spray Drying, Vacuum Concentration |
| End User | Food and Beverage Manufacturers, Pharmaceutical Companies, Nutraceutical Brands, Cosmetic Manufacturers, Tobacco Companies, Contract Manufacturers, Herbal Formulators |
| Nature | Organic, Conventional |
| Distribution Channel | Direct Sales, Ingredient Distributors, Online B2B Platforms, Specialty Herbal Ingredient Suppliers |
| Regions Covered | North America, Europe, East Asia, South Asia, Middle East and Africa |
| Countries Covered | USA, China, India, Germany, Japan, UK |
| Key Companies Profiled | Mafco Worldwide LLC, Norevo GmbH, Maruzen Pharmaceuticals Co., Ltd., F&C Licorice Ltd., Zagros Licorice Co., Sepidan Osareh Co., ASEH Licorice, VPL Chemicals, Givaudan (Naturex), Magnasweet, Ransom Naturals, Sanat Products Ltd., Gansu Fanzhi Pharmaceutical, Qinghai Blicsweet Licorice Technology, Others |
| Additional Attributes | Revenue analysis by product type and active compound profile, concentration band penetration assessment, country-level demand modeling, extraction method cost benchmarking, derivative portfolio analysis, compliance-driven procurement evaluation, pricing structure benchmarking, and competitive landscape concentration assessment |
The Global Licorice Extract Market is valued at USD 949.80 Million in 2026, reflecting manufacturer-level revenues from standardized extracts and purified derivatives across food, pharmaceutical, nutraceutical, cosmetic, tobacco, and feed applications.
The market is projected to reach USD 1,733.31 Million by 2036, supported by concentration-defined procurement models and derivative portfolio expansion across regulated and semi-regulated industries.
The Global Licorice Extract Market is expected to expand at a CAGR of 6.20% between 2026 and 2036.
The United States holds the largest share in the Global Licorice Extract Market, supported by structured pharmaceutical and nutraceutical manufacturing ecosystems that prioritize concentration-certified and documentation-ready botanical extracts.
Medium Glycyrrhizin concentration between 10 to 30% leads the market, accounting for 28.6% of the active compound profile share.
Powder (Solid Extract) accounts for the highest share within product types, representing 16.9% of the Global Licorice Extract Market.
Nutraceutical and Dietary Supplements lead the application landscape with a 13.9% share, followed by Confectionery at 13.4%.
Growth is primarily influenced by concentration standardization, assay documentation requirements, derivative portfolio expansion, extraction yield optimization, and integration into regulated pharmaceutical and nutraceutical formulations rather than raw root trade expansion alone.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Industry Share Analysis for Licorice Extract Companies
UK Licorice Extract Market Trends – Demand, Innovations & Forecast 2025-2035
USA Licorice Extract Market Insights – Size, Share & Industry Growth 2025-2035
ASEAN Licorice Extract Market Trends – Size, Demand & Forecast 2025-2035
Europe Licorice Extract Market Growth – Trends, Demand & Innovations 2025-2035
Australia Licorice Extract Market Analysis – Size & Industry Trends 2025-2035
North America Licorice Extract Market Size and Share Forecast Outlook 2025 to 2035
Latin America Licorice Extract Market Report – Growth, Demand & Forecast 2025-2035
Licorice Root Market Size, Growth, and Forecast for 2026-2036
Extraction Kits Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Licorice Candy Market Analysis - Size, Share & Forecast 2025 to 2035
Key Companies & Market Share in the Licorice Root Sector
Extracts and Distillates Market
UK Licorice Root Market Insights – Trends, Demand & Growth 2025-2035
USA Licorice Root Market Growth – Trends, Demand & Innovations 2025-2035
The Sage Extract Market is segmented by End Use Industries (Sage Extract for Food and Beverage, Sage Extract for Pharmaceuticals, and Sage Extract for Cosmeceuticals), Nature of Production (Organic Sage Extract and Conventional Sage Extract), Packaging (Amber Glass Sage Extract Bottle, Sage Extract Bottle with Dropper, and Plastic Sage Extract Bottle) and Region. Forecast for 2026 to 2036.
The Amla Extract Market is segmented by Product Form (Powder, Liquid, Others), Application (Food and Beverages, Pharmaceuticals, Skin Care, Hair Care, Nutraceuticals), and Region. Forecast for 2026 to 2036.
Neem Extract Market Size and Share Forecast Outlook 2025 to 2035
Fume Extractor Market Size and Share Forecast Outlook 2025 to 2035
Meat Extracts Market Size and Share Forecast Outlook 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.